Probiotics require precision — and that's exactly what we deliver.
In partnership with leading scientists and global research institutions, we formulate evidence-based probiotics designed to support key areas of health, including gastrointestinal, skin, oral, pediatric, and nutritional wellness.
For everyone, developed by science.
01 Research
Research published in eClinicalMedicine indicates that GLP-1 drugs can reduce the risk of obesity-related cancers by nearly 50%. These findings suggest that the benefits of GLP-1 RAs extend beyond weight loss and glycemic control.
A study published in JAMA Neurology found that GLP-1 RAs were associated with a 45% lower risk of developing dementia, including Alzheimer's disease. This suggests potential neuroprotective effects of these medications.
GLP-1 plays a crucial role in stimulating insulin secretion, reducing food intake, protecting the heart, and reducing systemic inflammation.
- Dr. Daniel J. Drucker, Endocrinologist and Researcher
GLP-1 therapies may confer neuroprotective benefits, potentially expanding their use in the prevention or delay of neurodegenerative conditions.
- Dr. Paul Edison, Consultant Physician and Clinical Senior Lecturer at Imperial College London
02 DEVELOPMENT
Developed in Partnership with Leading Scientists.
We collaborated with top researchers and scientific partners to develop a GLP-1 formula grounded in cutting-edge science. Every step of the process — from strain selection to formulation — was guided by data, clinical insight, and a shared commitment to advancing metabolic health through evidence-based innovation.
03 New Scientific Breakthroughs
Pushing the Boundaries of Metabolic Health.
We conducted in-depth research into a next-generation GLP-1 formula — rooted in science and driven by outcomes. Focused on metabolic function, appetite regulation, and long-term wellness, our goal was to develop a solution that supported the body's natural balance while meeting the highest standards of efficacy, safety, and innovation.